​
​

Lipocine Ownership | Who Owns Lipocine?

OverviewForecastRevenueFinancialsChart

Lipocine Ownership Summary

Lipocine is owned by 11.32% institutional investors, and 88.68% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.64% of its assets in Lipocine shares.

LPCN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockLipocine11.32%-88.68%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202348-11.11%10,021,220-4.82%118.00%15-138.33%
Dec 31, 20225414.89%10,528,336-2.33%118.02%1536.36%1220.00%
Sep 30, 202247-4.08%10,780,011-9.45%126.73%11-42.11%10-23.08%
Jun 30, 2022492.08%11,904,688-0.08%137.42%19-13.64%1344.44%
Mar 31, 2022489.09%11,914,59412.25%133.71%2237.50%9-35.71%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv141.08K2.64%-
Vanguard Institutional Extnd Mkt Idx Tr74.28K1.39%-
Fidelity Extended Market Index31.16K0.58%-1.90K
Vifag 2002 SICAV17.77K0.33%-
BlackRock Extended Equity Market K12.86K0.24%-5.00
NT Ext Equity Mkt Idx Fd - L7.67K0.14%-
Northern Trust Extended Eq Market Idx7.67K0.14%-
Fidelity Total Market Index7.59K0.14%-
Dimensional US Targeted Value ETF7.26K0.14%-
DFA US Targeted Value I6.92K0.13%3.09K

Recent Insider Transactions

DateNameRoleActivityValue
May 25, 2023Patel Mahesh V. CEO and PresidentBuy$43.79K
Mar 24, 2023Patel Mahesh V. CEO and PresidentBuy$48.00K
Mar 20, 2023Ono Richard Dana-Buy$1.36K
Mar 17, 2023Patel Mahesh V. CEO and PresidentBuy$16.50K
Nov 22, 2022Papapetropoulos Spyros-Buy$10.22K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1--
2023 Q21-
2023 Q13-
2022 Q42-

LPCN Ownership FAQ

Who Owns Lipocine?

Lipocine shareholders are primarily institutional investors at 11.32%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Lipocine's industry, Biotech Stocks , is 44.97%, which Lipocine falls below.

Does Blackrock own Lipocine?

BlackRock is not among the top 10 institutional shareholders of Lipocine.

Who is the top mutual fund holder of Lipocine shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lipocine shares, with 2.64% of its total shares outstanding invested in 141.08K Lipocine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools